SCHEMBL24333385

SCHEMBL24333385

Cc1cccc(C(C)C)c1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CCC3)cc2o1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.37
MAPT P10636 6/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34
TP53 P04637 4/20 0.33
LMNA P02545 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
POLB P06746 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
TRPA1 O75762 1/20 0.32
GSTO1 P78417 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469668 0.89 RXFP1 (0.36) RXFP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL24333962 0.88 TP53 (0.36) MAPTKMT2AMEN1ALDH1A1MAPK1
SCHEMBL29469605 0.87 RXFP1 (0.37) RXFP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL24334415 0.86 TP53 (0.37) RXFP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL29469659 0.85 RXFP1 (0.34) RXFP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL24333413 0.85 RXFP1 (0.34) RXFP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL29469656 0.84 S1PR3 (0.33) RXFP1MAPTKMT2AMEN1TP53
SCHEMBL24333957 0.84 S1PR3 (0.33) RXFP1MAPTKMT2AMEN1TP53
SCHEMBL24333653 0.83 ALDH1A1 (0.34) RXFP1MAPTKMT2AMEN1ALDH1A1
SCHEMBL29469685 0.83 ALDH1A1 (0.34) RXFP1MAPTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP claimed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO claimed
EP-4229048-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER The Broad Institute, Inc. (US) 2023-08-23 EP disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed